Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors

被引:49
作者
Jung, Nam-Chul [1 ]
Kim, Hee Jung [1 ]
Kang, Mi-Sun [2 ]
Lee, Jun-Ho [1 ]
Song, Jie-Young [3 ]
Seo, Han Geuk [4 ]
Bae, Yong-Soo [2 ,5 ]
Lim, Dae-Seog [1 ]
机构
[1] CHA Univ, Dept Appl Biosci, Lab Immune Cell Based Therapy, Songnam 463836, Gyeonggi Do, South Korea
[2] CreaGene Inc, Res Inst DC Immunotherapy, Gyeonggi Do 462120, South Korea
[3] Korea Inst Radiol & Med Sci, Dept Radiat Canc Sci, Seoul 139706, South Korea
[4] Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea
[5] Sungkyunkwan Univ, Dept Biol Sci, Gyeonggi Do 440746, South Korea
基金
新加坡国家研究基金会;
关键词
Dendritic cells; Photodynamic therapy; Immunotherapy; Heat shock proteins; HEAT-SHOCK PROTEINS; ADAPTIVE IMMUNE-RESPONSES; HEAT-SHOCK-PROTEIN-70 PEPTIDE COMPLEXES; ANTIGEN-PRESENTING CELLS; PULSED DENDRITIC CELLS; T-CELLS; INNATE; VACCINATION; RECEPTOR; CANCER;
D O I
10.1016/j.canlet.2012.04.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dendritic cell (DC)-mediated immunotherapy has not been as effective as expected for most solid tumors. This study demonstrates immune responses against solid tumors mediated by DCs charged with photodynamic therapy (PDT)-induced tumor lysates, which contain the heat shock protein (HSP) 70. PDT tumor lysate-pulsed DC (PDT-DC) inhibited the growth of mammary EMT6 tumors to a greater extent than freeze/thawed tumor lysate-pulsed DC (FT-DC) or PDT tumor lysates. PDT-DC also showed significant anti-tumor effects against fully-established (i.e., late-stage) solid tumors. Taken together, these results suggest that PDT-DC vaccination is more effective than conventional DC therapy for the treatment of cancers. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:58 / 65
页数:8
相关论文
共 41 条
[1]   Novel signal transduction pathway utilized by extracellular HSP70 -: Role of Toll-like receptor (TLR) 2 AND TLR4 [J].
Asea, A ;
Rehli, M ;
Kabingu, E ;
Boch, JA ;
Baré, O ;
Auron, PE ;
Stevenson, MA ;
Calderwood, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :15028-15034
[2]  
Asea A, 2003, EXERC IMMUNOL REV, V9, P25
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]  
Basu S, 2000, CELL STRESS CHAPERON, V5, P443, DOI 10.1379/1466-1268(2000)005<0443:HSPTFO>2.0.CO
[5]  
2
[6]   CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes [J].
Becker, T ;
Hartl, FU ;
Wieland, F .
JOURNAL OF CELL BIOLOGY, 2002, 158 (07) :1277-1285
[7]   Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells [J].
Berwin, B ;
Hart, JP ;
Rice, S ;
Gass, C ;
Pizzo, SV ;
Post, SR ;
Nicchitta, CV .
EMBO JOURNAL, 2003, 22 (22) :6127-6136
[8]   Essential role of CD91 in re-presentation of gp96-chaperoned peptides [J].
Binder, RJ ;
Srivastava, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) :6128-6133
[9]  
Castelli C, 2001, CANCER RES, V61, P222
[10]   Dendritic cells and immunotherapy for cancer [J].
Chang, DH ;
Dhodapkar, MV .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (05) :439-443